Dow Inc. (NYSE: DOW) 8-K adds securities description exhibit
Rhea-AI Filing Summary
Dow Inc. and The Dow Chemical Company filed a current report to handle an administrative task for their upcoming annual report. Instead of placing a detailed description of securities directly inside the Form 10‑K for the year ended December 31, 2025, they are submitting that description as Exhibit 4.5 to this 8‑K and incorporating it into the 10‑K by reference. The exhibit covers securities registered under Section 12 of the Securities Exchange Act of 1934. No earnings results, new financings, or major business events are disclosed in this report.
Positive
- None.
Negative
- None.
Commission File Number | Exact Name of Registrant as Specified in its Charter, Principal Office Address and Telephone Number | State or Other Jurisdiction of Incorporation | I.R.S. Employer Identification No. | ||||||||
( | |||||||||||
( | |||||||||||
| Registrant | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||
| Dow Inc. | Emerging Growth Company | ||||||||||
| The Dow Chemical Company | Emerging Growth Company | ||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Dow Inc. | ☐ | The Dow Chemical Company | ☐ | |||||||||||
| Exhibit No. | Exhibit Description | ||||
4.5 | Description of Securities registered under Section 12 of the Securities Exchange Act of 1934. | ||||
| 104 | Cover Page Interactive Data File. The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded with the Inline XBRL document. | ||||
| /s/ ANDREA L. DOMINOWSKI | ||
Andrea L. Dominowski Controller and Vice President of Controllers (Authorized Signatory and Principal Accounting Officer) | ||
FAQ
What did Dow Inc. (DOW) disclose in this 8-K filing?
The companies used this 8-K to file a detailed description of securities as Exhibit 4.5 and incorporate it into their Form 10‑K for the year ended December 31, 2025, mainly for administrative convenience and document size management.
Which companies are covered by this Dow Inc. (DOW) 8-K?
The report covers both Dow Inc. and The Dow Chemical Company. Each is identified with its own Commission File Number, Delaware incorporation, and the shared Midland, Michigan headquarters address and telephone number listed in the document.
What is Exhibit 4.5 in the Dow Inc. (DOW) 8-K?
Exhibit 4.5 is the “Description of Securities registered under Section 12 of the Securities Exchange Act of 1934.” It provides formal details on the securities each registrant has listed, and will be incorporated by reference into the upcoming Form 10‑K.
How does this 8-K relate to Dow Inc.’s 2025 Form 10-K?
The 8-K serves as a companion to the 2025 Form 10‑K by placing the description of securities in a separate exhibit. That exhibit is then incorporated by reference into the 10‑K, helping limit the size of the full annual report document.
Does this Dow Inc. (DOW) 8-K include financial results or earnings data?
No, the report does not present financial statements or earnings data. It focuses on filing Exhibit 4.5, describing securities registered under Section 12, and arranging for that exhibit to be incorporated into the Form 10‑K for administrative reasons.
Who signed the Dow Inc. and Dow Chemical 8-K submission?
The report was signed on behalf of Dow Inc. and The Dow Chemical Company by Andrea L. Dominowski, who is identified as Controller and Vice President of Controllers, serving as an authorized signatory and principal accounting officer.
